Bio Total Revenue from 2010 to 2025

TECH Stock  USD 64.92  0.57  0.87%   
Bio Techne's Total Revenue is increasing with slightly volatile movements from year to year. Total Revenue is estimated to finish at about 1.4 B this year. Total Revenue is the total amount of income generated by the sale of goods or services related to Bio Techne's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
1989-09-30
Previous Quarter
289.5 M
Current Value
297 M
Quarterly Volatility
87 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 134.9 M, Total Revenue of 1.4 B or Gross Profit of 929.4 M, as well as many indicators such as Price To Sales Ratio of 6.9, Dividend Yield of 0.0049 or PTB Ratio of 6.78. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
  
Check out the analysis of Bio Techne Correlation against competitors.

Latest Bio Techne's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Bio Techne Corp over the last few years. Total revenue comprises all receipts Bio Techne Corp generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Bio Techne's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Techne's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
738.931.1.1B1.1B1.2B1.3B1.4B26%19%3%2%15%5%100%
       Timeline  

Bio Total Revenue Regression Statistics

Arithmetic Mean729,389,809
Geometric Mean536,866,737
Coefficient Of Variation56.09
Mean Deviation337,229,911
Median714,006,000
Standard Deviation409,143,140
Sample Variance167398.1T
Range1.4B
R-Value0.99
Mean Square Error4376.1T
R-Squared0.98
Slope84,882,383
Total Sum of Squares2510971.6T

Bio Total Revenue History

20251.4 B
20241.3 B
20231.2 B
20221.1 B
20211.1 B
2020931 M
2019738.7 M

About Bio Techne Financial Statements

Investors use fundamental indicators, such as Bio Techne's Total Revenue, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Revenue1.3 B1.4 B

Currently Active Assets on Macroaxis

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.294
Dividend Share
0.32
Earnings Share
0.98
Revenue Per Share
7.568
Quarterly Revenue Growth
0.09
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Discover investing ideas

Utilize additional investing modules

News Freq…Investor S…100%